Canlyniadau Chwilio - David Berd
- Dangos 1 - 10 canlyniadau o 10
-
1
Laboratory Identification of Clinically Important Aerobic Actinomycetes gan David Berd
Cyhoeddwyd 1973Artigo -
2
Laboratory Identification of Clinically Important Aerobic Actinomycetes gan David Berd
Cyhoeddwyd 1973Artigo -
3
-
4
-
5
-
6
-
7
Deletion mapping of chromosome region 9p21-p22 surrounding theCDKN2 locus in melanoma gan Masataka Ohta, David Berd, Masayoshi Shimizu, Hirokazu Nagai, Maria‐Grazia Cotticelli, Michael J. Mastrangelo, Jerry A. Shields, Carol L. Shields, Carlo M. Croce, Kay Huebner
Cyhoeddwyd 1996Artigo -
8
High-Dose Immunoembolization: Survival Benefit in Patients with Hepatic Metastases from Uveal Melanoma gan Akira Yamamoto, Inna Chervoneva, Kevin L. Sullivan, David J. Eschelman, Carin F. Gonsalves, Michael J. Mastrangelo, David Berd, Jerry A. Shields, Carol L. Shields, Mizue Terai, Takami Sato
Cyhoeddwyd 2009Artigo -
9
Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor gan Takami Sato, David J. Eschelman, Carin F. Gonsalves, Mizue Terai, Inna Chervoneva, Peter A. McCue, Jerry A. Shields, Carol L. Shields, Akira Yamamoto, David Berd, Michael J. Mastrangelo, Kevin L. Sullivan
Cyhoeddwyd 2008Artigo -
10
Double-Blinded, Randomized Phase II Study Using Embolization with or without Granulocyte–Macrophage Colony-Stimulating Factor in Uveal Melanoma with Hepatic Metastases gan Matías E. Valsecchi, Mizue Terai, David J. Eschelman, Carin F. Gonsalves, Inna Chervoneva, Jerry A. Shields, Carol L. Shields, Akira Yamamoto, Kevin L. Sullivan, M. Laudadio, David Berd, Michael J. Mastrangelo, Takami Sato
Cyhoeddwyd 2015Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Cancer research
Internal medicine
Melanoma
Chemotherapy
Gastroenterology
Surgery
Biology
Cancer
Oncology
Cyclophosphamide
Ecology
Identification (biology)
Metastasis
Phases of clinical research
Regimen
Toxicity
Allele
Alternative medicine
Breast cancer
Carmustine
Cisplatin
Clinical endpoint
Clinical trial
Complete remission
Computational biology
Confidence interval
Cytokine
Dacarbazine
Diffuse large B-cell lymphoma